Clinical Trials Browser

Phase 1 × OTHER × merestinib × Clear all

NCT03292536 2021-01-08

Merestinib on Bone Metastases in Subjects With Breast Cancer

Phase 1 Terminated

Breast Neoplasms

NCT03125239 2020-06-30

Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute